Agenda

This session explores how AI can help cities move beyond treating disease to creating environments where people live longer and better, drawing inspiration from "Blue Zones" known for exceptional longevity. The event brings together technology, healthcare, and policy leaders to examine how cities like Singapore could pioneer the world's first AI-enabled Blue Zone city, using digital innovation and health data to translate longevity science into measurable societal outcomes.

Most organisations still can’t answer a simple question: Is this AI system actually ready for operational use? Accuracy metrics don’t translate into real-world performance — and testing rarely produces the evidence needed for a confident go / no-go decision. As AI moves beyond pilots into deployment, this gap becomes critical. This closed-door session focuses on the reality of AI assurance in practice — where testing and validation often break down, and where it remains unclear what it takes for a system to be ready for trusted deployment in the real world. Through guided working discussions, participants will explore real-world use cases, examine how AI systems are evaluated in practice, and surface where current approaches fall short. The session will also highlight structured ways to link testing outputs to decision-making — enabling clearer, evidence-based pathways from development to operational use.